We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.37%
2 Financials 4.87%
3 Healthcare 3.8%
4 Consumer Discretionary 3.79%
5 Industrials 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXI icon
351
CALL
iShares China Large-Cap ETF
FXI
$4.2B
$111M 0.05%
2,595,900
-1,561,900
-38% -$66.7M
CZR
352
DELISTED
Caesars Entertainment Corporation
CZR
$111M 0.05%
9,351,904
+5,325,704
+132% +$50.5M
CAT icon
353
Caterpillar
CAT
$397B
$111M 0.05%
810,993
-1,597,508
-66% -$211M
NOW icon
354
CALL
ServiceNow
NOW
$128B
$111M 0.05%
2,012,500
+660,000
+49% +$34.7M
IBB icon
355
CALL
iShares Biotechnology ETF
IBB
$9.89B
$110M 0.05%
1,006,000
+439,500
+78% +$46.7M
LOW icon
356
PUT
Lowe's Companies
LOW
$122B
$109M 0.05%
1,083,900
-88,500
-8% -$9.33M
MCD icon
357
CALL
McDonald's
MCD
$195B
$109M 0.05%
526,700
-77,400
-13% -$15.3M
MMM icon
358
PUT
3M
MMM
$94.6B
$109M 0.05%
750,251
+187,892
+33% +$28.9M
BIIB icon
359
PUT
Biogen
BIIB
$30.6B
$108M 0.05%
463,900
-88,700
-16% -$20.5M
DUK icon
360
Duke Energy
DUK
$96.3B
$108M 0.05%
1,228,262
+299,048
+32% +$26.4M
SEIC icon
361
SEI Investments
SEIC
$12.5B
$108M 0.05%
1,928,938
+1,383,869
+254% +$74.6M
GDX icon
362
CALL
VanEck Gold Miners ETF
GDX
$27.9B
$108M 0.05%
4,209,700
-147,600
-3% -$3.25M
DLTR icon
363
Dollar Tree
DLTR
$24.6B
$107M 0.05%
1,000,895
-1,081,951
-52% -$114M
EW icon
364
Edwards Lifesciences
EW
$53.5B
$107M 0.05%
1,741,434
-708,774
-29% -$42.9M
CNC icon
365
Centene
CNC
$33.1B
$107M 0.05%
2,033,012
+1,859,578
+1,072% +$100M
LULU icon
366
PUT
lululemon athletica
LULU
$13.9B
$106M 0.05%
589,900
-112,000
-16% -$19.5M
XRAY icon
367
Dentsply Sirona
XRAY
$2.25B
$106M 0.05%
1,818,704
+691,494
+61% +$37.2M
PG icon
368
Procter & Gamble
PG
$336B
$106M 0.05%
965,495
-963,950
-50% -$103M
AMGN icon
369
CALL
Amgen
AMGN
$226B
$106M 0.05%
573,400
+17,200
+3% +$3.08M
LW icon
370
Lamb Weston
LW
$7.27B
$106M 0.05%
1,666,296
-310,035
-16% -$20.5M
COR icon
371
Cencora
COR
$61.4B
$106M 0.05%
1,237,866
+519,082
+72% +$41M
PFE icon
372
PUT
Pfizer
PFE
$150B
$105M 0.05%
2,566,279
-281,418
-10% -$11.2M
VMC icon
373
Vulcan Materials
VMC
$36.4B
$105M 0.05%
768,154
+98,849
+15% +$12.6M
TLT icon
374
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.7B
$105M 0.05%
791,900
+123,700
+19% +$15.7M
TCBI icon
375
Texas Capital Bancshares
TCBI
$4.38B
$105M 0.05%
1,706,485
+866,838
+103% +$52.7M

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.